Regeneron Pharmaceuticals, Inc. vs Datadog, Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Regeneron Pharmaceuticals, Inc.
$81.5B
μμ #193
Datadog, Inc.
$82.8B
μμ #190
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Datadog, Inc.μ΄(κ°) 2026λ κΉμ§ Regeneron Pharmaceuticals, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Regeneron Pharmaceuticals, Inc. | Datadog, Inc. | μ λ |
|---|---|---|---|
| 2026 | $81.5B | $82.8B | Datadog, Inc. |
| 2025 | $79.3B | $45.0B | Regeneron Pharmaceuticals, Inc. |
| 2024 | $72.8B | $47.3B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $89.7B | $40.2B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.7B | $24.3B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $64.5B | $58.9B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $49.4B | $32.6B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $38.4B | $12.5B | Regeneron Pharmaceuticals, Inc. |